⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL25939003 | 0.77 | — | — | |
| SCHEMBL13188073 | 0.76 | PGR (0.38) | — | |
| SCHEMBL18782614 | 0.76 | PGR (0.38) | — | |
| SCHEMBL13713697 | 0.76 | PGR (0.38) | — | |
| SCHEMBL7766013 | 0.74 | — | — | |
| SCHEMBL16311872 | 0.71 | — | — | |
| SCHEMBL19144545 | 0.69 | CHRM2 (0.32) | — | |
| SCHEMBL18980132 | 0.68 | — | — | |
| SCHEMBL6135565 | 0.68 | — | — | |
| SCHEMBL11997982 | 0.68 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8759291-B2 | Methods of treatment using exendin peptides or GLP-1 peptides | AMYLIN PHARMACEUTICALS, LLC (US) | 2014-06-24 | — | — | US | disclosed |
| US-20110195904-A1 | METHODS OF TREATMENT USING EXENDIN PEPTIDES OR GLP-1 PEPTIDES | AMYLIN PHARMACEUTICALS, INC. (US) | 2011-08-11 | — | — | US | disclosed |